Advanced HRD Testing for Cancer - Homologous Recombination Deficiency (HRD) Testing
An advanced laboratory test analyzing genomic instability in tumors. It identifies patients likely to benefit from targeted therapies, specifically PARP inhibitors, in advanced ovarian and breast cancer cases.